These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6451720)

  • 1. [Subacute toxicity test of cefoperazone in beagle dogs with the intravenous administration for 3 months (author's transl)].
    Yoneda T; Masatani H; Shibata T; Kawamura Y; Sato S; Iwasaki S; Takimoto Y; Nagasawa M; Takai A
    Jpn J Antibiot; 1980 Oct; 33(10):1028-55. PubMed ID: 6451720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subacute toxicity test of cefoperazone in beagle dogs with the intramuscular administration for 3 months (author's transl)].
    Yoneda T; Kawamura Y; Sato K; Nagai A; Masatani H; Shibata T; Iwasaki S; Nagasawa M; Takimoto Y; Takai A
    Jpn J Antibiot; 1980 Oct; 33(10):1056-83. PubMed ID: 6451721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.
    Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK
    Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic toxicity study of latamoxef in beagle dog (author's transl)].
    Muraoka Y; Nara H; Yoshizaki T; Harada Y
    Jpn J Antibiot; 1982 Jan; 35(1):222-39. PubMed ID: 6461778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laboratory and clinical studies on cefoperazone in pediatrics treatment (author's transl)].
    Motohiro T; Takechi T; Soejima N; Watari H; Oohashi K; Sakata Y; Nishiyama T; Ezaki Y; Yokoyama T; Nakajima T; Komatsu Y; Ishimoto K; Tominaga K; Yamashita F; Takeya S; Yamamoto M; Ohkita R; Iriki T
    Jpn J Antibiot; 1980 Sep; 33(9):943-58. PubMed ID: 6452544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [General pharmacology of cefoperazone, a new cephalosporin antibiotic (author's transl)].
    Takai A; Hirai S; Watanabe I; Hiraiwa T; Abe N; Omori M; Muroda T; Nakajima S; Nakada Y; Tanada K; Senda N; Tanaka K; Makino H
    Jpn J Antibiot; 1980 Oct; 33(10):994-1018. PubMed ID: 6451724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Single dose oral toxicity study of BMY-28100 in juvenile rats and dogs].
    Kadota T; Kondoh H; Chikazawa H; Kawano S; Kuroyanagi K; Ohta S; Ishikawa K; Kai S; Kohmura H; Takahashi N
    Jpn J Antibiot; 1990 Jul; 43(7):1238-42. PubMed ID: 2232154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subacute (5 weeks) subcutaneous toxicity study of cefsulodin using 3-week-old juvenile beagle dogs].
    Tokiwa T; Miyoshi K; Takahashi T; Uda F
    Jpn J Antibiot; 1982 Nov; 35(11):1620-8. PubMed ID: 7169660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety evaluation of KW-1062. III. Investigation of maximum safety dose on subacute toxicity studies in dogs (author's transl)].
    Hara T; Koyama K; Miyazaki H; Ohguro Y; Shimizu M
    Jpn J Antibiot; 1977 Jun; 30(6):423-31. PubMed ID: 894838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subacute toxicity study of cefotiam in three-week old beagle puppies (author's transl)].
    Tokiwa T; Miyoshi K; Takahashi T; Uda F; Honda T; Hoshino S
    Jpn J Antibiot; 1981 May; 34(5):655-62. PubMed ID: 6270405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety evaluation of micronomicin. I. Subacute and chronic toxicity in dogs].
    Hara T; Nishikawa S; Miyazaki H; Ohguro Y
    Jpn J Antibiot; 1983 Jan; 36(1):150-73. PubMed ID: 6842822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental and clinical studies on cefoperazone (author's transl)].
    Toyonaga Y; Kurosu Y; Yoshikawa H; Kumagai K; Takahashi T; Hori M
    Jpn J Antibiot; 1980 Aug; 33(8):820-40. PubMed ID: 6451729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
    Han J; Shin HC; Kim JC; Kim B
    Food Chem Toxicol; 2004 Mar; 42(3):373-80. PubMed ID: 14871579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies on cefoperazone treatment for bile duct infections (author's transl)].
    Hirayama T; Kikuchi K
    Jpn J Antibiot; 1981 Jun; 34(6):934-8. PubMed ID: 6457179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [6-week intravenous toxicity test of cefpiramide in rhesus monkeys].
    Suzuki H; Yoshida T; Ozaki H; Miki H; Shiobara Y
    Jpn J Antibiot; 1983 Jun; 36(6):1411-34. PubMed ID: 6655798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fundamental and clinical studies of cefoperazone in children (author's transl)].
    Yamaguchi H; Nishikawa K; Ogawa A; Kuno K; Kondo K
    Jpn J Antibiot; 1980 Aug; 33(8):841-51. PubMed ID: 6451730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic studies on the concomitant administration of piperacillin and cefazolin, and piperacillin and cefoperazone in rabbits.
    Hayashi T; Watanabe Y; Kumano K; Kitayama R; Yasuda T; Saikawa I; Totsuka K; Kumada T; Shimizu K
    J Antibiot (Tokyo); 1986 May; 39(5):699-712. PubMed ID: 3733519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxicological studies of a new cephamycin, MT-141. II. Its subacute toxicity in rats].
    Kurebe M; Yokota M; Yuda Y; Sasaki H; Niizato T; Watanabe H; Hayasaka H
    Jpn J Antibiot; 1984 May; 37(5):855-89. PubMed ID: 6434761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of whooping cough and whooping cough syndrome by cefoperazone (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Shishido H; Watanabe K; Matsumoto K; Tazaki K; Oki S; Araki H; Takajo N; Yuasa K; Tanaka Y; Tsugawa S; Nagayama K; Komatsu R; Yamamoto M; Ookita R; Sakaguchi Y; Terasawa K; Kinoshita M
    Jpn J Antibiot; 1980 Nov; 33(11):1183-93. PubMed ID: 6264178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activity of cefoperazone against anaerobic bacteria (author's transl)].
    Imamura H; Kobayashi T; Murata K; Kohbata S; Watanabe I; Marui T; Watanabe K; Ninomiya K; Ueno K; Suzuki S
    Jpn J Antibiot; 1980 Nov; 33(11):1171-82. PubMed ID: 6454011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.